JP2011509244A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509244A5
JP2011509244A5 JP2010539934A JP2010539934A JP2011509244A5 JP 2011509244 A5 JP2011509244 A5 JP 2011509244A5 JP 2010539934 A JP2010539934 A JP 2010539934A JP 2010539934 A JP2010539934 A JP 2010539934A JP 2011509244 A5 JP2011509244 A5 JP 2011509244A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
specific targeting
administration
tumor
brain tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011509244A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/087977 external-priority patent/WO2009086284A1/en
Publication of JP2011509244A publication Critical patent/JP2011509244A/ja
Publication of JP2011509244A5 publication Critical patent/JP2011509244A5/ja
Pending legal-status Critical Current

Links

JP2010539934A 2007-12-21 2008-12-22 脳の原発性神経腫瘍および神経膠腫における脳腫瘍幹細胞マーカーならびに診断および治療標的としてのcd24 Pending JP2011509244A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1638107P 2007-12-21 2007-12-21
PCT/US2008/087977 WO2009086284A1 (en) 2007-12-21 2008-12-22 Cd24 as a brain tumor stem cell marker and a diagnostic and therapeutic target in primary neaural and glial tumors of the brain

Publications (2)

Publication Number Publication Date
JP2011509244A JP2011509244A (ja) 2011-03-24
JP2011509244A5 true JP2011509244A5 (cg-RX-API-DMAC10.html) 2012-05-17

Family

ID=40824698

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010539934A Pending JP2011509244A (ja) 2007-12-21 2008-12-22 脳の原発性神経腫瘍および神経膠腫における脳腫瘍幹細胞マーカーならびに診断および治療標的としてのcd24

Country Status (5)

Country Link
US (1) US20110002846A1 (cg-RX-API-DMAC10.html)
EP (1) EP2231184A4 (cg-RX-API-DMAC10.html)
JP (1) JP2011509244A (cg-RX-API-DMAC10.html)
CA (1) CA2709380A1 (cg-RX-API-DMAC10.html)
WO (1) WO2009086284A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1249521A1 (zh) 2015-05-07 2018-11-02 肿瘤免疫股份有限公司 Cd24用於降低低密度脂蛋白胆固醇水平的用途
CN114381491A (zh) * 2020-10-22 2022-04-22 复旦大学附属儿科医院 一种神经母细胞瘤相关的肿瘤细胞标志物及其应用
CN116478999B (zh) * 2023-01-16 2024-04-05 广西师范大学 免疫抑制分子cd24核酸适体的筛选及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2556752C (en) * 2004-02-23 2016-02-02 Genentech, Inc. Heterocyclic self-immolative linkers and conjugates
US7837980B2 (en) * 2004-03-02 2010-11-23 Seattle Genetics, Inc. Partially loaded antibodies and methods of their conjugation
PL1766017T3 (pl) * 2004-06-10 2015-08-31 Viventia Bio Inc Przeciwciało specyficzne wobec nowotworu
US20080305044A1 (en) * 2004-11-29 2008-12-11 Seattle Genetics, Inc. Engineered Antibodies and Immunoconjugates
CN101360830A (zh) * 2005-12-08 2009-02-04 健康研究股份有限公司 Flj13639基因相关疾病的诊断和治疗方案
KR20080002341A (ko) * 2006-06-30 2008-01-04 재단법인서울대학교산학협력재단 Cd24를 표적으로 하는 암 억제방법
WO2009063461A1 (en) * 2007-11-14 2009-05-22 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Methods of treating cancer using anti cd24 antibodies

Similar Documents

Publication Publication Date Title
US20240408251A1 (en) Compositions and methods for targeted particle penetration, distribution, and response in malignant brain tumors
Chakravarty et al. Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized 198Au nanoparticles for targeted cancer therapy
JP6412918B2 (ja) マルチモーダルシリカ系ナノ粒子
Ding et al. Image guided biodistribution and pharmacokinetic studies of theranostics
CN102395380B (zh) 预靶向试剂盒、方法和其中使用的试剂
Maeda et al. Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor
JP2010017189A5 (cg-RX-API-DMAC10.html)
CN102438656B (zh) 预靶向试剂盒、方法和其中使用的试剂
EP2522369A1 (en) Pretargeting kit, method and agents used therein
JP2010530745A (ja) 腫瘍の画像化および/または処置のための微生物
JP2009512641A (ja) [3+2]アジド−アルキン環付加を使用するターゲットにされたイメージング及び/又は治療
CA3174263A1 (en) Immunotheranostic agent targeting mesenchymal stem cell-derived cancer cells and mesenchymal stem cell associated disease
JP2008515876A (ja) イメージング及び治療用のイメージング及び治療のエンドキットにおけるシュタウディンガーライゲーションの使用
US12281161B2 (en) Polypeptides and uses thereof
JP2016528299A (ja) ビタミンb12および内因子を含む組成物およびその使用方法
Miyasato et al. A path toward the clinical translation of nano‐based imaging contrast agents
Zhang et al. Multimodality molecular imaging of CD105 (Endoglin) expression
DE60320398T2 (de) Methoden und medizinische zusammensetzungen zur intravesikalen behandlung von blasenkrebs
Fortin et al. Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2: 342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma
Zhang et al. Bright semiconductor quantum dots shed new light on precision nanomedicine for various diseases
US12268742B2 (en) Nanotherapeutic systems and methods using particle-driven photodynamic therapy (PDT)
GB2516882A (en) Tumour-targeted theranostic
WO2012047582A2 (en) Compositions useful for target, detection, imaging and treatment, and methods of production and use thereof
Chen et al. Bone-seeking albumin-nanomedicine for in vivo imaging and therapeutic monitoring
EP3946472A1 (en) Targeting compounds for cancers selected from esophagus, pharynx and larynx, lung, brain, and intestines